Dysadherin augmented cancer cell binding to fibronectin, resulting in increased integrin activation; hence, we sought to determine the role of dysadherin in myosin IIa organization using dysadherin-OE or dysadherin-KO CRC cells plated on fibronectin-coated coverslips. This evidence concerns the gene FXYD5 and cancer.